Today's Technical View on Covidien, Becton, Dickinson and Co., Antares Pharma, and DENTSPLY Intl.
LONDON, March 6, 2013 /PRNewswire/ --
The healthcare industry is undergoing major transformation following the passage of President Obama's Affordable Care Act (ACA). While the ACA is expected to create significant opportunities for healthcare companies in the long-run, some aspects of the reform have been faced criticism. One such feature is the 2.3% tax that medical instruments & supplies companies such as Covidien Plc (NYSE: COV), Becton, Dickinson and Co. (NYSE: BDX), Antares Pharma Inc. (NASDAQ: ATRS), and DENTSPLY International Inc. (NASDAQ: XRAY) have to pay on gross sales. The tax has been opposed by the medical instruments & supplies industry, which says that it will hurt innovation. On Tuesday, medical instruments & supplies stocks edged higher, tracking gains in the broad market. StockCall initiated free in-depth technical analysis on COV, BDX, ATRS, and XRAY which are currently available upon sign up at
Shares of Covidien Plc rose sharply in Tuesday's trading session, closing 1.17% higher at $64.71, which is also the stock's 52-week high. Volume stood at 1.56 million, below the daily average of 2.39 million. Covidien's shares have outperformed the broad market so far in 2013, gaining more than 12%. Yesterday, the stock broke through $64 resistance level, which is a bullish signal. The bullish trend is further confirmed by recent volume activity and the stock's MACD chart. The stock's MACD has just crossed above the signal line. Sign up for the free technical analysis on COV at
Shares of Becton, Dickinson and Co. rose marginally in Tuesday's trading session. The stock closed 0.60% higher at $89.19 on volume of 1.04 million. The company's shares also reached a 52-week high of $89.30 yesterday. Year-to-date, the stock has now gained more than 14%, easily outperforming the broad market. Becton, Dickinson and Co.'s shares had been trading sideways over the past few weeks; however, the stock has now broken through a key technical level. The stock is also trading well above its 50-day and 200-day moving averages. Download the free report on BDX by registering at
Shares of Antares Pharma Inc. rose sharply in Tuesday's trading session. The stock closed 3.69% higher at $3.65 on volume of 838,410. The company's shares have now gained more than 6% in the last three trading sessions. Year-to-date, the stock has outperformed the broad market, gaining more than 10%. ATRS had fallen sharply last month after failing to break through $4 resistance level. The stock bottomed out at around $3.40 and has rebounded sharply. The stock's MACD has just crossed above the signal line, which is a bullish signal. The free report on ATRS can be downloaded by signing up now at
Shares of DENTSPLY International Inc. rose sharply in Tuesday's trading session, tracking gains in the broad market. The stock closed 1.74% higher at $42.01 on above average volume of 888,494. It touched an intra-day high of $42.29. Year-to-date, DENTSPLY's shares have now gained more than 6%. The stock has just crossed above its 50-day moving average, which is a bullish signal. The bullish trend is further confirmed by recent volume activity. Free report on XRAY can be accessed by registering at
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at